Tetraethyl pyrophosphate in the myasthenia gravis.
D006801:Humans; D009157:Myasthenia Gravis / Q000628:therapy*; D009388:Neostigmine / Q000378:metabolism*; D009943:Organophosphorus Compounds / Q000627:therapeutic use*
D009943:Organophosphorus Compounds; C005799:tetraethyl pyrophosphate; D009388:Neostigmine
MYASTHENIA GRAVIS/therapy; NEOSTIGMINE/metabolism; TETRAETHYL PYROPHOSPHATE/therapeutic use